论文部分内容阅读
临床收治的许多进展期肿瘤 ,术后多采用联合化疗为主的综合疗法。联合化疗方案可增加抗癌效果而不增加药物的毒性 ,或降低而不减少疗效。Chiou-J[1 ]的 期临床实验证明 ELF临床治疗胃癌有较高的有效率 ,且该方案具有耐受性好 ,副反应轻微的优点 ,特别适合于高龄及伴有其它并发
Many of the advanced tumors that are clinically treated are postoperatively treated with combination chemotherapy. The combination chemotherapy regimen can increase the anti-cancer effect without increasing the toxicity of the drug, or decrease without reducing the efficacy. Clinical trials of Chiou-J[1] showed that ELF has a higher clinical efficacy in the treatment of gastric cancer, and this program has the advantages of good tolerability and slight side effects. It is particularly suitable for advanced age and other concurrent concurrences.